Expert Review of Clinical Pharmacology

NOV 5, 2026 · REVIEW

Rethinking endpoints for anti-obesity pharmacotherapy in patients with hr+ early breast cancer receiving endocrine therapy: from body weight and BMI to body composition

Expert Review of Clinical Pharmacology

INTRODUCTION: Body weight (BW) and body mass index (BMI) are commonly used to assess obesity and response to weight-management interventions in patients with hormone receptor-posit

OCT 30, 2026 · JOURNAL ARTICLE

From metabolic therapy to addiction care: a clinical pharmacology roadmap for GLP-1 receptor agonists in substance use disorders

Expert Review of Clinical Pharmacology

INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), established treatments for type 2 diabetes and obesity, are being investigated for substance use disorders (SUD

SEP 22, 2026 · JOURNAL ARTICLE

Theranostics in the management of prostate cancer: from concept to clinical practice

Expert Review of Clinical Pharmacology

INTRODUCTION: Radiotheranostics, integrating diagnostic imaging with targeted radiotherapy using molecularly matched radioactive agents, has emerged as a transformative approach in